Latest Content

As Cases of Bladder Cancer Rise, One Organization Can Help Educate and Connect Patients

February 24th 2021, 10:00pm

By Jessica Skarzynski


To discuss the projected rise in bladder cancer cases in 2021, CURE® spoke with Bladder Cancer Advocacy Network (BCAN) co-founder Diane Zipursky-Quale, who offered some insight on why the numbers continue to rise, and provides some hope in the form of educational programs offered by her organization.

Equity Report Card: Advocacy Organizations Offer Recommendations to Combat Racial Disparities in Cancer Care

February 24th 2021, 7:00pm

By Kristie L. Kahl


After a recent poll reported negative experiences among Black and Latinx patients during their cancer care, the National Comprehensive Cancer Network, American Cancer Society Cancer Action Network and National Minority Quality Forum recommended practice changes to prevent racial disparities moving forward.

Celebrating the End of Cancer Treatment by Creating a Life-Long Memory

February 24th 2021, 5:00pm

By Debbie Legault


A caregiver recalls how she and her daughter went to get tattoos to celebrate the end of her daughter’s breast cancer treatment. Now, every time she looks down at her tattoo, she can smile knowing her daughter conquered cancer.

Responses to Therapy for Ovarian and Other Women’s Cancers May Have to be Assessed Beyond Imaging and Blood Test Modalities

February 24th 2021, 4:00pm

By Darlene Dobkowski, MA


Two evaluations for treatment responses in women with ovarian, fallopian tub or primary peritoneal carcinoma may need to take into consideration other factors such as other existing conditions.

Oral Sex Timing and Intensity Could Be Risk Factors of Oropharyngeal Cancer

February 24th 2021, 2:00pm

By Colleen Moretti


Patients with oropharyngeal cancer demonstrate higher rates of ever performing, timing, number of partners and intensity in oral sex than matching participants, suggesting an association between behavior and diagnosis.

How One Organization is Helping People Navigate the ‘Pain, Confusion and Chaos’ of a Cancer Diagnosis

February 23rd 2021, 10:00pm

By Ryan McDonald


A cancer diagnosis often comes with concerns of what’s next for patients. One concern is how they’re going to afford their treatments. Here, a panel of experts discuss what options are available.

Shattering Myths: How Patients With Cancer Can Become Better Health Advocates

February 23rd 2021, 7:00pm

By Ryan McDonald


There are two myths that patients with cancer believe when it comes to being health advocates. Here, a panel of experts look to dispel those myths to help patients become better advocates.

After Weighing the Pros and Cons of Getting a COVID-19 Vaccine, I Decided to Get One

February 23rd 2021, 5:00pm

By Tamera Anderson-Hanna


A cancer survivor reflects on her decision to receive a COVID-19 vaccine when it was made available to her.

‘WhatsApp’ Text Message Reminder Improves Adherence to Long-Term Screening for Colorectal Cancer

February 23rd 2021, 4:00pm

By Colleen Moretti


Sending a text message reminder to participants about their upcoming fecal immunochemical test improved previously poor adherence rates for colorectal cancer screening.

Immunotherapy Combinations Offer ‘Hope and Promise’ for Patients with Advanced Renal Cell Carcinoma

February 23rd 2021, 2:00pm

By Jessica Skarzynski


Positive results from the phase 3 CLEAR clinical trial, presented at the 2021 ASCO Genitourinary Cancers Symposium, are just one more dataset that could offer “a sense of hope and promise” for patients with advanced renal cell carcinoma (RCC), says the study’s lead author, Dr. Robert J. Motzer.

Cancer Survivors, Patients Share Their Favorite Motivational or Inspirational Quote

February 22nd 2021, 8:30pm

By Ryan McDonald


On social media, CURE® recently asked its readers to share their favorite motivational or inspirational quotes. Here's what they had to share.

FDA Approves Front-Line Libtayo for Advanced Non-Small Cell Lung Cancer Subset

February 22nd 2021, 6:41pm

By Jessica Skarzynski


The Food and Drug Administration has approved first-line Libtayo (cemiplimab-rwlc) monotherapy for patients with advanced non-small cell lung cancer with a PD-L1 expression of 50% or greater.

Make Room For The Under-65s: What the COVID-19 Vaccine Rollout Has Taught Me About My 'Value'

February 22nd 2021, 5:00pm

By Martha Carlson


Vaccine eligibility forces this metastatic breast cancer patient to confront the value society places on her life.

Fear of Recurrence: Identify Risks, Learn to Cope

February 22nd 2021, 4:00pm

By Brielle Benyon


There are certain patient characteristics that are associated with fear of recurrence. However, there are simple steps that survivors can take to cope.

Knocking Out Chronic Myeloid Leukemia with Precision

February 22nd 2021, 2:00pm

By Katie Kosko


Patients with chronic myeloid leukemia are living longer, some even stopping treatment, thanks to a plethora of targeted therapies.